AstraZeneca is finally admitting that blood clots are a very real side effect of their COVID vaccine for the first time ever in court.
According to the New York Post:
AstraZeneca has admitted that its COVID-19 vaccine could cause a rare but deadly blood-clotting condition, potentially exposing the UK pharmaceutical giant to tens of millions in lawsuits brought by loved ones of those injured or killed as a result of the jab.
Lawyers representing “dozens” of class-action claimants say some of their clients’ cases could be worth as much as $25 million, calling the Cambridge-headquartered pharma firm’s vaccine “a defective product,” according to the Daily Mail.
AstraZeneca, which is contesting the claims, acknowledged in a February legal document that its vaccine can “in very rare cases” cause a condition called thrombosis with thrombocytopenia syndrome, or TTS. TTS can cause patients to suffer blood clots as well as a low blood platelet count, which in some cases have seriously harmed or even killed recipients of the company’s vaccine.
So far, 51 cases have been filed in London’s High Court, estimated to be worth around $125 million total, the outlet writes.
Like in the U.S, the UK government struck a deal with AstraZeneca (and other COVID vaccine makers) to protect them from future lawsuits. However, in the UK it’s not virtually impossible to sue a vaccine maker - it’s just the taxpayer who is on the hook from any payouts resulting from lawsuits.
